Trial · NCT01289821
Adverse events110
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
81 to 100 of 110
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Lymph node pain | Blood and lymphatic system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Acute coronary syndrome | Cardiac disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Atrial fibrillation | Cardiac disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Atrial flutter | Cardiac disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 2 |
| serious | Abdominal pain | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Colonic obstruction | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Constipation | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Diarrhea | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 3 |
| serious | Gastrointestinal disorders - Other, specify | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Pancreatitis | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Small intestinal obstruction | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 3 |
| serious | Vomiting | Gastrointestinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Fever | General disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 3 |
| serious | Infusion related reaction | General disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 2 |
| serious | General disorders and administration site conditions - Other, specify | General disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Cholecystitis | Hepatobiliary disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Blood bilirubin increased | Investigations | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Catheter related infection | Infections and infestations | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Infections and infestations - Other, specify | Infections and infestations | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Sepsis | Infections and infestations | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01289821/events?page=5